Study Details
Single and multiple dosing study in hemodialysis patients with hyperphosphatemia in Japan
Clinicaltrials.gov ID
Astellas Study ID
3325-CL-0003
EudraCT ID
N/A
Condition
Kidney Disease, Increased Phosphate in Blood
Phase
Phase 1
Age
20 years - 74 years
Sex
Female & Male
Product
N/A
Type
Interventional
Trial Dates
May 2014 - Nov 2014
Masking
None (Open Label)
Enrollment number
24
A Phase 1, Single and Multiple Dosing Study to Evaluate Pharmacokinetics and Pharmacodynamics of ASP3325 in Patients with Chronic Kidney Disease and Hyperphosphatemia Undergoing Hemodialysis
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for Single and multiple dosing study in hemodialysis patients with hyperphosphatemia in Japan? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Site: 5
Aichi, Japan
Site: 2
Ibaraki, Japan
Site: 4
Aichi, Japan
Site: 3
Shizuoka, Japan
Site: 1
Ibaraki, Japan